First drug approved for neurofibromas is a MEK inhibitor

被引：2
|
作者：
不详
机构：
来源：
NATURE BIOTECHNOLOGY | 2020年 / 38卷 / 05期
关键词：
D O I：
10.1038/s41587-020-0530-3
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：513 / 513
页数：1
相关论文
共 50 条
  • [11] First fusion inhibitor approved for HIV
    不详
    INFECTIONS IN MEDICINE, 2003, 20 (04) : 206 - +
  • [12] First Approved Kinase Inhibitor for AML
    Rsko, John E. J.
    Hughes, Timothy P.
    CELL, 2017, 171 (05) : 981 - 981
  • [13] BRAF-MEK inhibitor combo approved for adjuvant melanoma therapy
    De Lartigue, Jane
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2018, 16 (06): : E228 - E230
  • [14] First biosimilar drug approved in the USA
    Burki, Talha Khan
    LANCET ONCOLOGY, 2015, 16 (04): : E161 - E161
  • [15] First drug approved for treatment of phenylketonuria
    Thompson, Cheryl A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (02) : 100 - 100
  • [16] Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1
    Sarin, Kavita Y.
    Bradshaw, Mark
    O'Mara, Chris
    Shahryari, Jahanbanoo
    Kincaid, John
    Kempers, Steven
    Tu, John H.
    Dhawan, Sunil
    Dubois, Janet
    Wilson, David
    Horwath, Patrice
    de Souza, Mark P.
    Powala, Christopher
    Kochendoerfer, Gerd G.
    Plotkin, Scott R.
    Webster, Guy F.
    Le, Lu Q.
    SCIENCE ADVANCES, 2024, 10 (18):
  • [17] Quick and sustained clinical response to MEK inhibitor I in a NF1 patient with neurofibromas
    Papalia, Honore
    Audic, Frederique
    Riviere, Gabriel Revon
    Verschuur, Arnauld
    Andre, Nicolas
    ECANCERMEDICALSCIENCE, 2018, 12
  • [18] Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib A Nonrandomized Clinical Trial
    Gross, Andrea M.
    Reid, Olivia H.
    Baldwin, Lauren A.
    Cannon, Ashley
    Choo-Wosoba, Hyoyoung
    Steinberg, Seth M.
    Lobbous, Mina
    Wolters, Pamela L.
    Pichard, Dominique C.
    Tibery, Cecilia M.
    Dombi, Eva
    Derdak, Joanne
    Widemann, Brigitte C.
    Korf, Bruce R.
    JAMA DERMATOLOGY, 2025,
  • [19] First proteasome inhibitor approved for multiple myeloma
    Twombly, R
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) : 845 - 845
  • [20] First protease inhibitor approved for treatment of HIV
    Nightingale, SL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (04): : 273 - 273
12345